Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

Extracellular vesicles could offer precise treatments for psychiatric conditions by targeting brain networks.

JAK inhibitors show promise for treating skin diseases effectively and safely.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Activating δ-opioid receptors can help hair grow.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

The inhibitor affects androgen metabolism but not ovarian function.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Black cumin and its nanoformulations show promise in treating neurodegenerative diseases.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

Nanospanlastic vesicles can improve glaucoma treatment by enhancing drug delivery to the eye.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

QLT0267 stops hair follicle cell growth and movement.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The cuneate nucleus has two main neuron types: relay neurons and interneurons.

Stopping alcohol after long-term use causes anxiety and changes brain chemicals.

TAK-279 effectively reduces psoriasis symptoms and is safe.

New therapies like JAK inhibitors, PRP, and stem cell treatments show promise for better alopecia management.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.